Editor: Vikas Anand Saharan

Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms

eBook: US $129 Special Offer (PDF + Printed Copy): US $219
Printed Copy: US $155
Library License: US $516
ISBN: 978-1-68108-460-2 (Print)
ISBN: 978-1-68108-459-6 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810845961170101

Introduction

Fast Dissolving/Disintegrating Dosage Forms (FDDFs) have been commercially available since the late 1990s. FDDFs were initially available as orodispersible tablets, and later, as orodipsersible films for treating specific populations (pediatrics, geriatrics, and psychiatric patients). Granules, pellets and mini tablets are among latest additions to these dosage forms, which are still in the development pipeline. As drug delivery systems, FDDFs enable quicker onset of action, immediate drug delivery, and sometimes offer bioavailability benefits due to buccal/sublingual absorption. With time, FDDF have evolved to deliver drugs in a sustained and controlled manner. Their current market and application is increasing in demands with advances in age adapted dosage forms for different patients and changing regulatory requirements that warrant mandatory assessments of new drugs and drug products before commercial availability.

This book presents detailed information about FDDFs from their inception to recent developments. Readers will learn about the technical details of various FDDF manufacturing methods, formulation aspects, evaluation and methods to conduct clinical studies. The authors also give examples of marketed fast disintegrating/dissolving drug products in US, Europe, Japan, and India. This reference is ideal for pharmacology students at all levels seeking information about this specific form of drug delivery and formulation.

Foreword

- Pp. i-ii (2)
Sanjay Garg
Download Free

Preface

- Pp. iii-iv (2)
Vikas A. Saharan
Download Free

List of Contributors

- Pp. v
Vikas A. Saharan
Download Free

Fast Dissolving/Disintegrating Dosage Forms: Introducing through Development, Market, Pharmacopoeial and Regulatory Status

- Pp. 3-18 (16)
Vikas A. Saharan, Anupama Singh, Vandana Kharb
View Abstract

Freeze Drying Technologies for Developing Fast Dissolving/Disintegrating Tablets

- Pp. 19-40 (22)
Vikas A. Saharan
View Abstract

Modifications in Conventional Tablet Compaction Technologies for Developing Fast Dissolving/ Disintegrating Tablets

- Pp. 41-98 (58)
Vikas A. Saharan
View Abstract

Moulding, Extrusion, Floss and Three Dimensional Printing Technologies for Developing Fast Dissolving/Disintegrating Tablets

- Pp. 99-118 (20)
Vikas A. Saharan
View Abstract

Patent Innovations in Fast Dissolving/ Disintegrating Dosage Forms

- Pp. 119-174 (56)
Kalpana Nagpal, Shailendra K. Singh, D. N. Mishra
View Abstract

Excipients for Fast Dissolving /Disintegrating Tablets

- Pp. 175-212 (38)
Vikas A. Saharan
View Abstract

Taste Masking in Fast Dissolving/Disintegrating Dosage Forms

- Pp. 213-251 (39)
Vikas A. Saharan, Vandana Kharb, Anupama Singh
View Abstract

Quality Assurance and Evaluation of Fast Dissolving/Disintegrating Dosage Forms

- Pp. 252-285 (34)
Vikas A. Saharan
View Abstract

Clinical Studies on Fast Dissolving/Disintegrating Dosage Forms

- Pp. 286-317 (32)
Prashant Mathur, Arpita Jindal, Sokindra Kumar, Vikas A. Saharan
View Abstract

Fast Dissolving Oral Films

- Pp. 318-356 (39)
Mahaveer Singh, Hemant R. Jadhav
View Abstract

Novel Fast Dissolving/Disintegrating Dosage Forms

- Pp. 357-377 (21)
Vikas A. Saharan
View Abstract

Approved and Marketed Fast Dissolving/ Disintegrating Drug Products

- Pp. 378-430 (53)
Vikas A. Saharan, Anupama Singh, Vandana Kharb
View Abstract

Subject Index

- Pp. 431-436 (6)
Vikas A. Saharan
Download Free

RELATED BOOKS

.Brain Tumor Targeting Drug Delivery Systems: Advanced Nanoscience for Theranostics Applications.
.Localized Micro/Nanocarriers for Programmed and On-Demand Controlled Drug Release.
.Advanced Pharmaceutical and Herbal Nanoscience for Targeted Drug Delivery Systems Part II.
.Advanced Pharmaceutical and Herbal Nanoscience for Targeted Drug Delivery Systems Part I.